Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1178 record(s)

Req # A-2020-000063

Adverse Reaction Report (AER). Report numbers: E2B_02928614, E2B_02934756, E2B_02951574.

Organization: Health Canada

51 page(s)
May 2020

Req # A-2020-000084

Adverse Reaction Report (AER). Report number: 000705709.

Organization: Health Canada

7 page(s)
May 2020

Req # A-2020-000117

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, Priorities to Address Aging Information Technology.

Organization: Health Canada

7 page(s)
May 2020

Req # A-2020-000120

Adverse Reaction Report (AER). Report numbers: 000737101, 000737106.

Organization: Health Canada

32 page(s)
May 2020

Req # A-2020-000129

Adverse Reaction Report (AER). Report numbers: E2B_02885721, E2B_02891230, E2B_02894317, E2B_02898124, E2B_02898148.

Organization: Health Canada

67 page(s)
May 2020

Req # A-2020-000205

Adverse Reaction Report (AER) for Cabazitaxel for Injection. Report number: 02487497. ADR for Daptomycin for Injection (350 mg/vial). Report number: 02460009. ADR for Janumet. Report numbers: 02333856, 02333864, 02333872.

Organization: Health Canada

0 page(s)
May 2020

Req # A-2019-001850

Adverse Reaction Report (AER). Report number: E2B_02781314.

Organization: Health Canada

43 page(s)
March 2020

Req # A-2015-000172

All documentation regarding the establishment of bioequivalence or therapeutic or clinical equivalence of subsequent-entry inhaled respiratory medication.

Organization: Health Canada

459 page(s)
March 2020

Req # A-2018-001153

All Briefing Notes regarding the suspension and potential revocation of Agrima Botanicals Corp (Ascent Industries Corp. subsidiary) from September 1, 2018 to December 31, 2018.

Organization: Health Canada

1 page(s)
March 2020

Req # A-2018-001634

All communications plans or strategies, and consultation plans or strategies, developed to guide communications products or activities directed to the Canadian public related to the coming into force of the Cannabis Act. Timeframe: September 2016 to…

Organization: Health Canada

234 page(s)
March 2020
Date modified: